tiprankstipranks
Trending News
More News >
Benitec Biopharma Ltd (BNTC)
NASDAQ:BNTC
US Market

Benitec Biopharma (BNTC) Income Statement

Compare
310 Followers

Benitec Biopharma Income Statement

Last quarter (Q1 2026), Benitec Biopharma's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Benitec Biopharma's net income was $-13.56M. See Benitec Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 75.00K$ 73.00K$ 59.00K
Gross Profit
$ -396.00K$ -343.00K$ -306.00K$ 64.00K$ -64.00K
Operating Expenses
$ 41.37M$ 22.25M$ 18.77M$ 17.92M$ 13.53M
Depreciation and Amortization
$ 69.33K$ 343.00K$ 381.00K$ 392.00K$ 424.00K
EBITDA
$ -41.70M$ -21.41M$ -19.15M$ -17.85M$ -13.45M
Operating Income
$ -41.77M$ -22.60M$ -19.08M$ -17.85M$ -13.60M
Other Income/Expenses
$ 3.85M$ 847.00K$ -481.00K$ -354.00K$ -286.00K
Pretax Income
$ -37.92M$ -21.75M$ -19.56M$ -18.21M$ -13.88M
Net Income
$ -37.92M$ -21.75M$ -19.56M$ -18.21M$ -13.88M
Per Share Metrics
Basic EPS
$ -1.05$ -2.68$ -14.12$ -19.31$ -27.27
Diluted EPS
$ -1.05$ -2.68$ -14.12$ -19.31$ -27.27
Weighted Average Shares Outstanding
36.21M 10.26M 1.39M 1.92M 1.01M
Weighted Average Shares Outstanding (Diluted)
36.21M 10.28M 1.39M 1.92M 1.01M
Currency in USD

Benitec Biopharma Earnings and Revenue History